5 Things To Know: CalAIM Incentive Program, Monoclonal Antibody Treatments, Resources For Front-Line Staff
MONOCLONAL ANTIBODIES: The California Department of Public Health (CDPH) has issued a COVID-19 Therapeutics Needs Assessment survey to understand how frequently antiviral medications and monoclonal antibody treatments are being used in each jurisdiction and/or health care facility. The survey is designed to help CDPH understand challenges and successes in outpatient treatment of COVID-19. As the landscape of outpatient therapeutics is changing rapidly, there have been several versions of this survey. Hospitals are encouraged to complete the survey even if another version was previously completed. More information on COVID-19 therapeutics options is available on the CDPH COVID-19 treatments page.